Convenient and ultrasensitive detection
of pesticides is demanded
for healthcare and environmental monitoring, which can be realized
with a dual-modal strategy. In this paper, based on a biotin-labeled
IgG-modified gold nanoparticle (AuNP@IgG-bio) probe, a dual-modal
immunosensor was proposed for detecting chloroacetamide herbicides.
This platform is relied on the dephosphorylation of ascorbic acid
2-phosphate (AA2P) by alkaline phosphatase (ALP). In addition to this
process, ascorbic acid (AA)-triggered deposition of silver on gold
nanostars (AuNSs) and the fluorogenic reaction of dehydrogenated AA
and o-phenylenediamine (OPD) occur sequentially.
Thus, the dual readout of the color change of red-green-blue (RGB)
and fluorescence generation in situ induced by crystal growth can
be used. The limits of detection (LODs) were as low as 1.20 ng/mL
of acetochlor (ATC), 0.89 ng/mL of metolachlor, 1.22 ng/mL of propisochlor,
and 0.99 ng/mL of their mixture by a smartphone and 0.44 ng/mL of
ATC, 1.59 ng/mL of metolachlor, 2.80 ng/mL of propisochlor, and 0.72
ng/mL of their mixture by a spectrofluorometer. The recoveries from
corn were 91.4–105.1% of the colorimetric mode and 92.4–106.2%
of the fluorescent mode. Due to its simple observation mode and good
performance, this dual-modal immunosensor possesses considerable application
prospects.
α-Toxin, one of the best known pore-forming proteins produced by Staphylococcus aureus (S. aureus), is a critical virulence factor in multiple infections. The necessity of α-toxin for S. aureus pathogenicity suggests that this toxin is an important target for the development of a potential treatment strategy. In this study, we showed that lysionotin, a natural compound, can inhibit the hemolytic activity of culture supernatants by S. aureus by reducing α-toxin expression. Using real-time PCR analysis, we showed that transcription of hla (the gene encoding α-toxin) and agr (the locus regulating hla) was significantly inhibited by lysionotin. Lactate dehydrogenase and live/dead assays indicated that lysionotin effectively protected human alveolar epithelial cells against S. aureus, and in vivo studies also demonstrated that lysionotin can protect mice from pneumonia caused by S. aureus. These findings suggest that lysionotin is an efficient inhibitor of α-toxin expression and shows significant protection against S. aureus in vitro and in vivo. This study supports a potential strategy for the treatment of S. aureus infection by inhibiting the expression of virulence factors and indicates that lysionotin may be a potential treatment for S. aureus pneumonia.
Given the great harm of pesticide residues to the environment and public health, exploring ultrasensitive and low-cost methods for their quantitative analysis becomes intensely necessary. Herein, we proposed a double-functionalized gold nanoparticle (AuNP) probe as a signal amplification immunoassay for the detection of acetochlor (ATC), metolachlor, and propisochlor. The AuNP was modified with IgG and fluorophore-labeled duplex DNA by a polyadenine-based freezing method. The quenched fluorescence can be effectively recovered via duplex-specific nuclease (DSN) with excellent cleaving activity. This approach provided limits of detection (LODs) down to 0.03 ng/mL for ATC, 0.10 ng/mL for metolachlor, 0.14 ng/mL for propisochlor, and 0.08 ng/ mL for their mixture. The average recoveries of ATC, metolachlor, and propisochlor were 93.0−106.6% from a corn sample, which are in good agreement with the commercial kit (R 2 = 0.9995). This "turn-off" fluorescence immunoassay presents considerable potential in the analysis of chloroacetamide herbicide due to its simple process of probe preparing and ultrahigh sensitivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.